From Left to right: Enitan Odeyemi, Director, Business Development, Codix Pharma Ltd; Mary Ogangwu - Chief Operating Officer, Codix Pharma Ltd; Kingsley Aguoru - Chief Operating Officer, Colexa ...

Codix Bio Limited has been selected as the first African manufacturing partner selected by the World Health Organization (WHO), SD Biosensor, and the Medicines Patent Pool (MPP) under the WHO Health ...

For decades, imported diagnostics have dominated African hospitals. From syringes to test kits, the continent has relied heavily on supplies from Europe, Asia, and North America. This dependency has ...

Codix Pharma Limited, a fast-growing pharmaceutical company in Nigeria, has unveiled a new head office complex in Ilupeju Lagos, as part of efforts towards complementing the efforts of Government in ...

Codix Pharma has launched Codix Bio, its second in-vitro diagnostics manufacturing facility, focusing on the local production of rapid diagnostic test (RDT) kits for malaria, HIV, Hepatitis B and C, ...

Following the successful Change Notification (CN) approval from the World Health Organization (WHO), Colexa Biosensor Limited, a subsidiary of Codix Group, is now licensed to package a WHO ...

Codix Pharma's journey in the Nigerian pharmaceutical industry is one of innovation, strategic leadership, and a bold commitment to leading the way in health-tech solutions. Since it commenced ...

In a landmark move that would transform Nigeria's healthcare landscape, Codix Pharma Ltd is preparing to inaugurate Codix Bio Ltd, the country's first large-scale facility for the local production of ...

The World Health Organisation (WHO) has approved Codix Group, a subsidiary of Colexa Biosensor Ltd, to package a WHO Prequalified Rapid Diagnostic Test kit at its factory in Nigeria. Colexa Biosensor, ...

The United States, the world's largest humanitarian aid donor, has cut funding for foreign assistance, half of which is delivered via USAid. The US support to Nigeria, which reached $740m in 2024 ...